---
status: pending
tags: [Leprosy, MDT, CommunicableDiseases, Pharmacology, PublicHealth, Prevention, Dapsone, Rifampicin]
subject: Community Medicine
topic: COMMUNICABLE DISEASES
up: 175
---

# [[COMMUNICABLE DISEASES]] > Objectives in multi drug therapy in Leprosy

# Objectives of Multi-Drug Therapy (MDT) in Leprosy

The introduction of [[Multi-Drug Therapy]] (MDT) marked a paradigm shift from dapsone monotherapy, which was leading to widespread drug resistance. The World Health Organization (WHO) Study Group recommended MDT to address the challenges of leprosy control effectively,,.

### **Core Objectives**

The three primary objectives of MDT in leprosy are:

1.  **Interrupt Transmission:** To break the chain of transmission in the community by rendering infectious patients non-infectious as rapidly as possible using potent [[bactericidal drugs]],,.
2.  **Prevent Drug Resistance:** To prevent the emergence of drug-resistant strains of [[Mycobacterium leprae]] (both primary and secondary resistance), which was a major failure of the dapsone monotherapy era,,.
3.  **Cure and Prevention of Disability:** To ensure early detection and complete treatment of cases to achieve a cure, thereby preventing the development of associated **deformities** and disabilities,,.

### **Advantages of MDT**

Beyond the core objectives, MDT offers significant operational and clinical advantages:

*   **Shorter Duration:** It considerably curtails the duration of treatment (from lifelong to 6â€“12 months), reducing the workload on the health delivery system,.
*   **Cost-Effectiveness:** Shorter treatment periods make the program more economically viable.
*   **Patient Compliance:** A finite, shorter treatment period improves patient adherence to the drug regimen,.

---

### **Components of MDT**

MDT utilizes a combination of bactericidal and bacteriostatic agents to achieve these objectives.

| Drug | Role/Action | Key Characteristics |
| :--- | :--- | :--- |
| **[[Rifampicin]]** | **Highly Bactericidal** | The most powerful drug; kills 99.9% of viable organisms in a single dose. Essential for rapid sterilization,. |
| **[[Dapsone]]** | **Weak Bactericidal** | Cheap, safe, and effective. Used in combination to maintain suppression,. |
| **[[Clofazimine]]** | **Bacteriostatic & Anti-inflammatory** | Inhibits bacterial multiplication and suppresses [[Lepra reactions]]. Used mainly in Multibacillary cases,. |

> [!warning] Diagram Alert
> Flowchart showing the mechanism of action of Rifampicin, Dapsone, and Clofazimine on Mycobacterium leprae and how combination prevents resistance

---

### **Mnemonic: R.I.P. Leprosy**

To remember the three main objectives of MDT:

*   **R** - **R**esistance Prevention (Stop the superbugs!)
*   **I** - **I**nterrupt Transmission (Stop the spread!)
*   **P** - **P**revent Deformity / **P**romote Cure (Save the limbs!)

---

### **Clinical Relevance**

*   **Fixed Duration Therapy:** Unlike tuberculosis where treatment extension is common, in leprosy, treatment is stopped after a fixed duration (6 months for Paucibacillary, 12 months for Multibacillary) regardless of smear status, relying on the immune system to clear remaining dead bacilli,.
*   **Surveillance:** Because MDT aims to prevent relapse, clinical surveillance is mandatory after treatment completion (2 years for Paucibacillary, 5 years for Multibacillary) to monitor for recurrence,.
*   **Pregnancy:** MDT is considered safe during pregnancy and breastfeeding; stopping it can lead to exacerbation of the disease.

---
**Previous:** [[Morphological index]]  **Next:** [[Contact tracing in STDs]]